SLC22A17 and neoplasm: The stratification of tumor samples according to the methylation value of these probesets revealed that the expression levels of SLC22A17 (ENSG) were the highest (median: 4.41, IQ range: 3.47–5.48) in Group 1 with hypomethylation of cg23464698 and hypermethylation of cg16420801 while the samples of Group 4 with the lowest SLC22A17 expression levels (median: 1.72, IQ range: 0.51–2.82) showed an opposite trend of methylation levels for both CG probesets.